A narrative review of mutant isocitrate dehydrogenase AML in Japan based on experience with ivosidenib in AGILE. Hiramatsu Y, Urata S, Ishikawa T, Yamauchi T, et al. Int J Hematol 2026;123:509-515.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hiramatsu Y, Urata S, Ishikawa T, Yamauchi T, et al. A narrative review of mutant isocitrate dehydrogenase AML in Japan based on experience with ivosidenib in AGILE. Int J Hematol 2026;123:509-515.
PMID: 41774395